Search

Your search keyword '"Basch, Ethan"' showing total 1,616 results

Search Constraints

Start Over You searched for: Author "Basch, Ethan" Remove constraint Author: "Basch, Ethan"
1,616 results on '"Basch, Ethan"'

Search Results

2. Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE®)

3. Patient-Reported Tolerability in Oncology Drug Development

7. Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials – insights from an expert virtual roundtable

8. Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium

10. Evaluating Treatment Tolerability Using the Toxicity Index With Patient-Reported Outcomes Data

13. Comparing the Effectiveness of Electronic Symptom Monitoring versus Usual Care in Improving Survival among Patients with Metastatic Cancer -- The PRO-TECT Trial

16. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study

18. The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology.

20. Impact of real-world remote symptom monitoring program on hospitalizations and ICU admissions.

21. Comparison of symptom clusters between Black and White patients with cancer within an electronic patient-reported outcome remote symptom monitoring program.

22. Patient and provider perceptions of the benefits and limitations of implementing ePRO-driven remote symptom monitoring into real-world cancer care settings.

24. Pain severity among Black and White patients with cancer within a remote symptom monitoring program using electronic patient-reported outcomes.

25. Engagement Among Diverse Patient Backgrounds in a Remote Symptom Monitoring Program.

26. Evaluating the implementation and impact of navigator-supported remote symptom monitoring and management: a protocol for a hybrid type 2 clinical trial

27. A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer

28. The impact of self-reported social determinants of health (SDOH) on patient engagement and symptom burden across a remote patient monitoring (RPM) pathway in 42 European hospitals.

30. SAT-476 Development of a preference elicitation tool for treatment choice in unresectable, early/intermediate stage HCC

31. PD40-05 GIST OVERRIDES NUMERIC RISK PERCEPTION IN SURGICAL DECISION-MAKING

35. Comparing Two Types of Blood Thinners to Prevent Blood Clots in Patients with Cancer – The CANVAS Trial

37. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

38. Adaptation of Remote Symptom Monitoring Using Electronic Patient-Reported Outcomes for Implementation in Real-World Settings

39. Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.

41. Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC)

42. International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium

46. Methods for Developing Patient-Reported Outcome-Based Performance Measures (PRO-PMs)

47. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

50. Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

Catalog

Books, media, physical & digital resources